Elda University Hospital Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2018
NCT03211286
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Alejandro Lizaur-Utrilla, PhD, MD | Elda University Hospital | Orthopaedic Surgery Department, Elda University Hospital